The Sentinel Principle®
The Scientific Observation that Circulating Blood Reflects, in a Detectable Way, What is Occurring Throughout the Body.
As early pioneers in liquid biopsies, we developed one of the first blood-based biomarker tests for the early identification of Colorectal Cancer (ColonSentry®).Today, more than 100,000 patients in the U.S. have benefited from the ColonSentry test.
One of the strengths of the Sentinel Principle is its flexibility. Applying it to different disease areas enables our scientists to generate specific combinations of biomarkers for numerous applications and medical conditions. This enables us to focus on the clinical questions and diseases with the greatest unmet need and largest opportunities to improve care.